Trademarkia Logo

Australia

AU$
Trademark Search
FROM NEUTRON TO PATIENT

View On IPO.GOV.AU

FROM NEUTRON TO PATIENT
Protected: Registered/protected

Last updated on 31 Jan 2024

Owner Info

POINT Biopharma USA Inc.

4850 West 78th St.

Indianapolis IN 46268, UNITED STATES OF AMERICA

Serial Number

2267557 filed on 31 Mar 2022

Correspondent

Karen Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo

One Financial Center,

Boston MA 02111,

UNITED STATES OF AMERICA

FROM NEUTRON TO PATIENT

Classification Information

Class [005]
Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncol Read More

Class [042]
Pharmaceutical research and development services; providing medical research information in the fields of pharmaceuticals, oncology and nuclear medici Read More

Mark Details

Serial Number

2267557

Registered On

31 Mar 2022

Renewal On

31 Mar 2032

Mark Type

WORD

Priority Claim (Convention Details)

Date

12 Oct 2021

Mark Type

US

Legal History

Show more

Status DateAction Taken
31st Jan 2024Customer Amendment Made correspondence sent
31st Jan 2024Amendment to Address for Service Requested
19th Jul 2022International Registration in Australia Protected correspondence sent
18th Jul 2022IP Right Registration Published
18th Jul 2022Status change to Registered/Protected
10th May 2022Application Accepted correspondence sent
9th May 2022IP Right has been Examined
9th May 2022IP Right Acceptance Published
9th May 2022Status change to Accepted
6th May 2022Awaiting examination